Sökresultat

Filtyp

Din sökning på "*" gav 570681 sökträffar

Cecilia von Schéele has defended her thesis

This article is over 5 years old, and the information may therefore be outdated. Cecilia von Schéele defended her dissertation "The void: Urban wasteland as political space" today at 10:00 in Edens Hörsal, Paradisgatan 5h, Lund. External reviewer: Associate Professor Nils Hertting, Uppsala University.The void: Urban wasteland as political spaceCecilia von Schéele’s personal page 

https://www.svet.lu.se/en/article/cecilia-von-scheele-has-defended-her-thesis - 2026-06-21

Sjöstedt on why small states join big wars

This article is over 5 years old, and the information may therefore be outdated. Roxanna Sjöstedt, Erik Noreen and Jan Ångström have co-authored the article "Why small states join big wars: The case of Sweden in Afghanistan 2002–2014" in International Relations. Abstract:The security behavior of small states has traditionally been explained by different takes of realism, liberalism, or constructiv

https://www.svet.lu.se/en/article/sjostedt-why-small-states-join-big-wars - 2026-06-21

New immunotherapy initiative aims to bring research closer to the clinic and opens new tenure‑track positions

A new joint initiative in immunotherapy between Lund University and Skåne University Hospital, Sweden, brings researchers, clinicians and engineers together to shorten the path from research to patient benefit. The initiative is accompanied by the recruitment of three new tenure‑track Assistant Professors in immunotherapy through the Lund University Programme for Global Excellence. The initiative

https://www.stemcellcenter.lu.se/article/new-immunotherapy-initiative-aims-bring-research-closer-clinic-and-opens-new-tenure-track-positions - 2026-06-21

Prestigious international award for Martin L. Olsson

Martin L. Olsson has received the International Society for Blood Transfusion (ISBT) Presidential Award, the highest international honour in transfusion medicine. The award is presented every two years to a researcher who has made outstanding contributions to transfusion medicine. Martin L. Olsson is recognised for translational research on red blood cells, following 35 years of work mapping the g

https://www.stemcellcenter.lu.se/article/prestigious-international-award-martin-l-olsson - 2026-06-21

81 million SEK drives new international effort to study aging and epigenetic changes in Parkinson’s Disease

Every person ages, yet only some develop Parkinson’s Disease, and scientists still don’t know why. A new international effort involving a research team from Lund University aims to uncover what makes certain aging brains more vulnerable than others, focusing on the epigenetic changes that accompany growing older. Their work is supported by a new 81 million SEK grant from the Aligning Science Acros

https://www.stemcellcenter.lu.se/article/81-million-sek-drives-new-international-effort-study-aging-and-epigenetic-changes-parkinsons-disease - 2026-06-21

Early-life B cells can drive leukemia later in life

Researchers at the Lund Stem Cell Center, Lund University, have discovered that a population of B cells formed shortly after birth store long-term immune memory and, in mice, can give rise to leukemia much later in life. Published in Cell Reports, the findings reveal how immune events at the very beginning of life can leave lasting biological imprints, linking early development to disease in old a

https://www.stemcellcenter.lu.se/article/early-life-b-cells-can-drive-leukemia-later-life - 2026-06-21

Lund Stem Cell Center joins BEYOND European postdoctoral programme in advanced therapies

The Lund Stem Cell Center at Lund University is a partner in BEYOND, a new European postdoctoral training programme designed to prepare the next generation of researchers in advanced cell and gene therapies. Coordinated by Fondazione Telethon, the programme is supported by €6 million from the Horizon Europe Marie Skłodowska Curie Actions (MSCA) COFUND scheme and will fund 35 international postdoct

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-joins-beyond-european-postdoctoral-programme-advanced-therapies - 2026-06-21

STEM-PD enters a new chapter as Cellular Intelligence acquires global rights to advance the stem cell therapy for Parkinson's Disease

The STEM PD clinical trial, a stem cell–based approach for Parkinson’s disease, is entering a new phase in its development. In May 2026, Cellular Intelligence, an AI native biotech company, announced that it has acquired global rights from the Danish pharmaceutical company, Novo Nordisk, to further advance the clinical development of the STEM PD programme. STEM‑PD is among a small number of plurip

https://www.stemcellcenter.lu.se/article/stem-pd-enters-new-chapter-cellular-intelligence-acquires-global-rights-advance-stem-cell-therapy - 2026-06-21

A training ground for cell and gene therapies: New pre-GMP facility aims to smooth the path from idea to patient

When research findings are ready to make the leap from the lab to the patient, the requirements become much stricter. That is precisely where many promising projects start to falter. “We want to be the bridge between research and the patient, so that promising projects don’t get stuck in that difficult transition,” says Sara Nolbrant, director of the new pre-GMP facility. And with that, she disapp

https://www.stemcellcenter.lu.se/article/training-ground-cell-and-gene-therapies-new-pre-gmp-facility-aims-smooth-path-idea-patient - 2026-06-21

Lund Stem Cell Center welcomes four new research group leaders

Lund Stem Cell Center continues to grow as a leading hub for interdisciplinary stem cell research, welcoming four new principal investigators into its research community. Together, they bring specialised expertise spanning molecular and cell biology, immunology and bioengineering, further strengthening the Center’s scientific scope and possibilities for collaboration. How cells protect their DNA,

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-welcomes-four-new-research-group-leaders - 2026-06-21

Welcome two new Principal Investigators to Lund Stem Cell Center

This article is over 5 years old, and the information may therefore be outdated. Principal Investigators Daniella Ottosson and Charlotta Böiers have been accepted to join Lund Stem Cell Center.A warm welcome to the Ottosson and Böiers groups. To learn more about their research, the following Stem Cell Talks have been scheduled: Wednesday 25th September: Principal Investigator Daniella Ottosson. De

https://www.stemcellcenter.lu.se/article/welcome-two-new-principal-investigators-lund-stem-cell-center - 2026-06-21

Tailored therapy for chronic myeloid leukaemia

This article is over 5 years old, and the information may therefore be outdated. Chronic myeloid leukaemia (CML) is a slowly progressing form of blood cancer that attacks the blood-forming cells in the bone marrow. The condition requires lifelong treatment that can cause severe side effects. Rebecca Warfvinge maps stem cells in patients in the hope of identifying predictive markers for how the pat

https://www.stemcellcenter.lu.se/article/tailored-therapy-chronic-myeloid-leukaemia - 2026-06-21

Cancerfonden supports research into the role of RNA modification in cancer development

This article is over 5 years old, and the information may therefore be outdated. The Swedish Cancer Foundation, Cancerfonden, has announced the researchers it will be supporting in its most recent round of funding and Lund Stem Cell Center was especially successful, with seven scientists awarded a total of almost 30 million SEK. Cristian Bellodi, a research team leader from the Division of Molecul

https://www.stemcellcenter.lu.se/article/cancerfonden-supports-research-role-rna-modification-cancer-development - 2026-06-21

Filipe Pereira awarded European Research Council Consolidator Grant

This article is over 5 years old, and the information may therefore be outdated. Today the European Research Council (ERC) announced the winners of its latest Consolidator Grant competition and Filipe Pereira, group leader in the Department of Laboratory Medicine, was one of the researchers awarded this highly competitive grant. One of 89 researchers selected from a total of 707 applicants in the

https://www.stemcellcenter.lu.se/article/filipe-pereira-awarded-european-research-council-consolidator-grant-0 - 2026-06-21

How self-reactive immune cells are allowed to develop

This article is over 5 years old, and the information may therefore be outdated. Directly after birth, the immune system completes production of a subtype of antibody-producing immune cells, B-1, that are to last for a lifetime. No more B1-cells are formed after that point. However, these cells are self-reactive – they produce not only antibodies against foreign substances, but also against the bo

https://www.stemcellcenter.lu.se/article/how-self-reactive-immune-cells-are-allowed-develop - 2026-06-21

How do dementia diseases affect our brains?

This article is over 5 years old, and the information may therefore be outdated. By Pia [dot] romare [at] fsi [dot] lu [dot] se (Pia Romare) - published on 23 August 2018“We must understand the ageing process itself in order to help people with conditions such as Alzheimer’s and dementia, and to possibly enable us to prevent these diseases from arising”, says Henrik Ahlenius of the Stem Cell Centr

https://www.stemcellcenter.lu.se/article/how-do-dementia-diseases-affect-our-brains - 2026-06-21

Prestigious scientific prize awarded to Director of Lund Stem Cell Center

This article is over 5 years old, and the information may therefore be outdated. Zaal Kokaia, Professor within the Department of Clinical Sciences and Director of Lund Stem Cell Center, has been awarded Georgia’s most prestigious scientific prize - the National Prize in Science.  The award comes as a result of his outstanding contribution to world class scientific research and was presented to Pro

https://www.stemcellcenter.lu.se/article/prestigious-scientific-prize-awarded-director-lund-stem-cell-center - 2026-06-21